Combined transhepatic and transsplenic recanalization of chronic splenic vein occlusion to treat left-sided portal hypertension: A cases report.
| Autor: | Liang J; School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan Province, China., Feng X; Department of Interventional, The Second People's Hospital of Yibin, Yibin, Sichuan Province, China., Peng M; School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan Province, China., Duan JT; Department of Interventional, The Second People's Hospital of Yibin, Yibin, Sichuan Province, China., Chen YY; Department of Interventional, The Second People's Hospital of Yibin, Yibin, Sichuan Province, China., Zhu J; Department of Interventional, The Second People's Hospital of Yibin, Yibin, Sichuan Province, China. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Medicine [Medicine (Baltimore)] 2024 Feb 02; Vol. 103 (5), pp. e37109. |
| DOI: | 10.1097/MD.0000000000037109 |
| Abstrakt: | Rationale: This report describes a unique case of a combination transhepatic and transsplenic recanalization of chronic splenic vein occlusion to treat left-sided portal hypertension (LSPH). Patient Concerns: In this case report, we report a 49-year-old male who was admitted due to LSPH causing black stools for 2 days and vomiting blood for 1 hour. Diagnoses: The patient has a history of multiple episodes of pancreatitis in the past. After admission, abdominal contrast-enhanced CT scan showed the appearance of pancreatitis, with extensive splenic vein occlusion and accompanied by gastric varicose veins, indicating the formation of LSPH. Intervention: The patient received treatment with a combination of splenic and hepatic splenic venoplasty. Outcomes: Follow up for 1 year, CT and gastroscopy showed disappearance of gastric varices. Lessons: Splenic venoplasty is an effective method for treating LSPH. When it is difficult to pass through the occluded segment of the splenic vein through a single approach, percutaneous double approach splenic venoplasty can be attempted for treatment. Competing Interests: The authors have no conflicts of interest to disclose. (Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|